$NAVB,,WOW,,shareholders voted down company seatin
Post# of 22755
Navidea Biopharmaceuticals (NAVB) slid 5.9% today after disappointed shareholders rejected a plan to issue a reverse split on the stock, and withheld approval for the company's board nominees.
• A 20-for-1 reverse split -- which would give a boost to a stock price that settled at $0.48 in today's brief session -- was rejected by 64% of voters.
• In addition, 41.6M shareholder votes went against seating CEO/Chairman Michael Goldberg on the board vs. 27.99M for, and 40.88M voted against Mark Greene vs. 28.7M for. The disapproval of the board nominees doesn't prevent them from being seated.
• Shares haven't risen above the $1 mark since September.
https://twitter.com/twitter/statuses/957208055766241280